New research suggests that living near major roads or highways is associated with incidence of non-Alzheimer dementia, Parkinson disease (PD), Alzheimer disease (AD), and multiple sclerosis (MS).
We found race and age disparities not only in who adopted patient portal technology but also in which features were accessed by those who were adopters.
The use of statewide data infrastructure is effective at identifying criteria for diabetes outreach and management at the whole-population level.
The authors advocate for a consideration of 2 distinct phases of obesity management (ie, active weight loss and maintenance of weight loss) to allow substantially more people access to antiobesity medications.
A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.
A disease management program for Medicare Advantage patients with diabetes and coronary artery disease resulted in significantly reduced hospital admissions and total healthcare costs.
NCODA presents findings from over 700 patient responses across the country to determine patient satisfaction over 4 categories: time, convenience, staff interaction, and overall satisfaction.
The National Quality Forum (NQF) Measure Incubator provides a platform for the development of patient-reported outcome performance measures in palliative cancer care, which is essential to understanding a cancer patient’s functional status and well being.
A business case is made for medical centers to offer high-quality clinical training experiences to recruit graduating health professionals.
A systematic review of the literature reporting the cost of dementia among Medicare managed care plans found a limited and dated body of evidence.
Biologic therapy for rheumatoid arthritis or multiple sclerosis was associated with lower use of some types of medical services within 2 to 3 years of initiation.
This paper describes a replicable process for standardizing disparate databases and methods to calculate cost and quality measures within and across states.
New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
Despite the Medicare Diabetes Prevention Program now being a covered benefit, there is inadequate availability of suppliers to reach Medicare beneficiaries with prediabetes.
Mitigating cost increases through preemptive care and clinical efficacy to reduce the disease burden of clinically at-risk patients.
A review of exemplary VHA-sponsored telemedicine interventions indicates that telemedicine can efficiently address patient healthcare needs.
How peer-to-peer, community support programs can educate and empower patients to become more adherent to treatments, which will improve outcomes and reduce healthcare costs.